These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 7083193

  • 1. Basic studies on aminoglutethimide.
    Salhanick HA.
    Cancer Res; 1982 Aug; 42(8 Suppl):3315s-3321s. PubMed ID: 7083193
    [Abstract] [Full Text] [Related]

  • 2. Steroid hormone profiles in women treated with aminoglutethimide for metastatic carcinoma of the breast.
    Samojlik E, Santen RJ, Kirschner MA, Ertel NH.
    Cancer Res; 1982 Aug; 42(8 Suppl):3349s-3352s. PubMed ID: 7083199
    [Abstract] [Full Text] [Related]

  • 3. Pharmacology of aminoglutethimide: structure/activity relationships and receptor interactions.
    Nicholls PJ, Daly MJ, Smith HJ.
    Breast Cancer Res Treat; 1986 Aug; 7 Suppl():S55-67. PubMed ID: 3755630
    [Abstract] [Full Text] [Related]

  • 4. Effects of aromatase inhibitors, aminoglutethimide, and 4-hydroxyandrostenedione on cyclic rats and rats with 7,12-dimethylbenz(a)anthracene-induced mammary tumors.
    Wing LY, Garrett WM, Brodie AM.
    Cancer Res; 1985 Jun; 45(6):2425-8. PubMed ID: 3921242
    [Abstract] [Full Text] [Related]

  • 5. Preservation of androgen secretion during estrogen suppression with aminoglutethimide in the treatment of metastatic breast carcinoma.
    Samojlik E, Veldhuis JD, Wells SA, Santen RJ.
    J Clin Invest; 1980 Mar; 65(3):602-12. PubMed ID: 6986409
    [Abstract] [Full Text] [Related]

  • 6. Inhibition of estrogen synthetase (aromatase) by 4-cyclohexylaniline.
    Kellis JT, Vickery LE.
    Endocrinology; 1984 Jun; 114(6):2128-37. PubMed ID: 6723577
    [Abstract] [Full Text] [Related]

  • 7. In vivo and in vitro pharmacological studies of aminoglutethimide as an aromatase inhibitor.
    Santen RJ, Santner SJ, Tilsen-Mallett N, Rosen HR, Samojlik E, Veldhuis JD.
    Cancer Res; 1982 Aug; 42(8 Suppl):3353s-3359s. PubMed ID: 7083200
    [Abstract] [Full Text] [Related]

  • 8. Induction of aromatase expression by aminoglutethimide, an aromatase inhibitor that is used to treat breast cancer in postmenopausal women.
    Kao YC, Okubo T, Sun XZ, Chen S.
    Anticancer Res; 1999 Aug; 19(3A):2049-56. PubMed ID: 10470147
    [Abstract] [Full Text] [Related]

  • 9. Resistance of the ovary to blockade of aromatization with aminoglutethimide.
    Santen RJ, Samojlik E, Wells SA.
    J Clin Endocrinol Metab; 1980 Sep; 51(3):473-7. PubMed ID: 6773974
    [Abstract] [Full Text] [Related]

  • 10. Comparative studies of aromatase inhibitors in relation to the significance of estrogen synthesis in human mammary tumors.
    Abul-Hajj YJ.
    Cancer Res; 1982 Aug; 42(8 Suppl):3373s-3377s. PubMed ID: 6211227
    [Abstract] [Full Text] [Related]

  • 11. Stereoselective inhibition of aromatase by enantiomers of aminoglutethimide.
    Graves PE, Salhanick HA.
    Endocrinology; 1979 Jul; 105(1):52-7. PubMed ID: 446416
    [Abstract] [Full Text] [Related]

  • 12. Molecular Action and Clinical Relevance of Aromatase Inhibitors.
    Murphy MJ.
    Oncologist; 1998 Jul; 3(2):129-130. PubMed ID: 10388095
    [Abstract] [Full Text] [Related]

  • 13. Overview of recent development of aromatase inhibitors.
    Brodie AM.
    Cancer Res; 1982 Aug; 42(8 Suppl):3312s-3314s. PubMed ID: 7083192
    [Abstract] [Full Text] [Related]

  • 14. Inhibition of human placental progesterone synthesis by aminoglutethimide in vitro.
    Rabe T, Rabe D, Weidenhammer K, Runnebaum B.
    Int J Biol Res Pregnancy; 1982 Aug; 3(4):167-72. PubMed ID: 6961114
    [Abstract] [Full Text] [Related]

  • 15. Comparative studies of aromatase inhibitors in cultured human breast cancer cells.
    MacIndoe JH, Woods GR, Etre LA, Covey DF.
    Cancer Res; 1982 Aug; 42(8 Suppl):3378s-3381s. PubMed ID: 7083203
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Aromatase inhibitors: new endocrine treatment of breast cancer.
    Brueggemeier RW.
    Semin Reprod Med; 2004 Feb; 22(1):31-43. PubMed ID: 15083379
    [Abstract] [Full Text] [Related]

  • 18. Evaluation of the racemate and the enantiomers of a new highly active and selective aromatase inhibitor of the aminoglutethimide type.
    Hartmann RW, Grün G, Bartz U, Palzer M.
    J Steroid Biochem Mol Biol; 1992 Dec; 43(7):641-8. PubMed ID: 1472456
    [Abstract] [Full Text] [Related]

  • 19. Estrogen synthesis in human breast tumor and its inhibition by testololactone and bromoandrostenedione.
    Dao TL.
    Cancer Res; 1982 Aug; 42(8 Suppl):3338s-3341s. PubMed ID: 7083197
    [Abstract] [Full Text] [Related]

  • 20. High dehydroepiandrosterone-sulfate predicts breast cancer progression during new aromatase inhibitor therapy and stimulates breast cancer cell growth in tissue culture: a renewed role for adrenalectomy.
    Morris KT, Toth-Fejel S, Schmidt J, Fletcher WS, Pommier RF.
    Surgery; 2001 Dec; 130(6):947-53. PubMed ID: 11742322
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.